In The Emperor of All Maladies: A Biographic of Cancer, the oncologist Siddhartha Mukherjee, MD, intuits, “Down to their innate molecular core, cancer cells are hyperactive, survival-endowed, scrappy, fecund, inventive copies of ourselves.”1 Replace “cancer cells” with “viruses” and the quote holds equally true. Darwinian perpetrators of genomic dysregulation, many viruses have integrated foundationally into…
Of the 12 patients with COVID-19, 6 developed severe acute respiratory syndrome; 3 died.
Two studies show decreases in incidence and death rates, but variation by sex, race/ethnicity, age.
Although some patients with cancer are at higher risk of developing severe disease should they become infected, these experts suggest the precautions being given to the general population are sufficient — at least for now.
Research into opioid alternatives for cancer-related pain has stalled, however substance use disorders remain problematic.
The prescribing information for Talzenna (talazoparib; Pfizer) has been updated to include recommendations for patients with severe renal impairment.
Researchers suggested several criteria for determining drug value in a survey given to participants for feedback.
Financial sacrifices also reported, with hardship and sacrifices more common in survivors aged 18 to 64.
Investigators at UCSD sought to create a tool to help clinicians predict patients’ risk of persistent opioid use after treatment.
One in 5 patients report binge drinking, while one-third exceed moderate drinking levels.
